INFINITT Healthcare Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	108,824	102,392	95,750	85,860	88,286	78,170
Other Revenue	-	-	-	-	-	-0
Revenue	108,824	102,392	95,750	85,860	88,286	78,170
Revenue Growth	6.50%	6.94%	11.52%	-2.75%	12.94%	11.56%
Cost of Revenue	39,227	40,335	37,945	36,691	34,754	32,371
Gross Profit	69,597	62,057	57,805	49,169	53,532	45,799
Selling, General & Admin	34,846	35,478	37,969	34,086	33,565	27,952
Research & Development	8,287	7,745	9,208	8,635	8,039	7,378
Amortization of Goodwill & Intangibles	120.7	124.44	134.47	133.61	138.67	108.5
Other Operating Expenses	210.86	355.52	277.76	254.94	268.2	272.09
Operating Expenses	45,832	47,840	50,281	45,226	45,675	38,691
Operating Income	23,765	14,217	7,524	3,942	7,857	7,108
Interest Expense	-92.22	-106.84	-131.75	-132.38	-121.79	-118.18
Interest & Investment Income	3,575	3,267	3,004	1,779	1,164	743.52
Earnings From Equity Investments	27.47	21.43	-38.63	100.77	22.47	65.12
Currency Exchange Gain (Loss)	3,320	-514.66	3,627	675.15	-698.68	1,836
Other Non Operating Income (Expenses)	275.76	462.87	85.79	-12.43	320.9	2,311
EBT Excluding Unusual Items	30,870	17,346	14,070	6,353	8,544	11,946
Gain (Loss) on Sale of Investments	48,646	17,981	34,039	15,210	-11,648	14,071
Gain (Loss) on Sale of Assets	-2.67	13.93	-30.97	-5.79	0.46	-1.11
Asset Writedown	-	-	-0.08	-	-	-
Other Unusual Items	5.45	-	-	20.38	8.84	8.98
Pretax Income	79,519	35,341	48,079	21,578	-3,095	26,025
Income Tax Expense	14,688	8,588	7,516	3,972	-3,256	3,386
Earnings From Continuing Operations	64,831	26,753	40,562	17,606	160.93	22,639
Earnings From Discontinued Operations	-	-	-2,066	-818.3	-	-
Net Income to Company	64,831	26,753	38,497	16,788	160.93	22,639
Minority Interest in Earnings	-701.86	-348.5	-698.78	-326.95	-29.36	17.65
Net Income	64,129	26,405	37,798	16,461	131.57	22,656
Net Income to Common	64,129	26,405	37,798	16,461	131.57	22,656
Net Income Growth	211.29%	-30.14%	129.63%	12411.29%	-99.42%	239.02%
Shares Outstanding (Basic)	25	24	24	24	24	24
Shares Outstanding (Diluted)	25	24	24	24	24	24
Shares Change	1.12%	-0.04%	0.04%	-	-0.19%	0.19%
EPS (Basic)	2609.83	1083.20	1550.00	675.27	5.40	929.44
EPS (Diluted)	2609.83	1083.20	1550.00	675.27	5.00	928.00
EPS Growth	207.83%	-30.12%	129.54%	13405.31%	-99.46%	238.69%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	21,233	13,273	11,483	9,556	8,281	15,424
Free Cash Flow Per Share	864.09	544.50	470.89	392.03	339.72	631.52
Gross Margin	63.95%	60.61%	60.37%	57.27%	60.63%	58.59%
Operating Margin	21.84%	13.88%	7.86%	4.59%	8.90%	9.09%
Profit Margin	58.93%	25.79%	39.48%	19.17%	0.15%	28.98%
Free Cash Flow Margin	19.51%	12.96%	11.99%	11.13%	9.38%	19.73%
EBITDA	26,008	16,552	10,118	6,441	10,418	9,468
EBITDA Margin	23.90%	16.17%	10.57%	7.50%	11.80%	12.11%
D&A For EBITDA	2,243	2,335	2,594	2,498	2,561	2,360
EBIT	23,765	14,217	7,524	3,942	7,857	7,108
EBIT Margin	21.84%	13.88%	7.86%	4.59%	8.90%	9.09%
Effective Tax Rate	18.47%	24.30%	15.63%	18.41%	-	13.01%
Advertising Expenses	-	2,091	2,099	1,999	1,695	804.23